Actively Recruiting

Phase Not Applicable
Age: 0 - 80Years
All Genders
NCT05847270

Surgical Treatment of Irreducible Atlantoaxial Dislocation

Led by Peking University Third Hospital · Updated on 2024-01-08

70

Participants Needed

1

Research Sites

181 weeks

Total Duration

On this page

Sponsors

P

Peking University Third Hospital

Lead Sponsor

X

Xuanwu Hospital, Beijing

Collaborating Sponsor

AI-Summary

What this Trial Is About

At present, there is a lack of standardized, large-scale, and high-level evidence-based medicine research on the safety and effectiveness of treatment of irreducible atlantoaxial dislocation (IAAD).Based on this, the goal of this prospective randomized controlled study is to systematically investigate the optimal surgical approach (simple posterior approach and the combined anterior and posterior approach) for managing IAAD, providing insights into the most efficacious and safest course of action. And long-term follow-up will be conducted on patients to evaluate the safety and effectiveness of different surgical methods, and to develop diagnostic and treatment standards for irreducible atlantoaxial dislocation.

CONDITIONS

Official Title

Surgical Treatment of Irreducible Atlantoaxial Dislocation

Who Can Participate

Age: 0 - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 0 and 80 years
  • Diagnosed with irreducible atlantoaxial dislocation confirmed by preoperative imaging and skull traction with 1/6 body weight
  • Eligible for surgical treatment
  • Provided informed consent personally or through a legal representative
Not Eligible

You will not qualify if you...

  • Presence of medical conditions that significantly affect surgery, such as malignant metastasis or infections
  • Critically ill patients unsuitable for surgery
  • Patients who refuse to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking University Third Hospital

Beijing, Beijing Municipality, China, 100191

Actively Recruiting

Loading map...

Research Team

S

Shenglin Wang, MD

CONTACT

S

Shilin Xue, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here